(Q46779292)

25 December 2017

title

ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats (English)

1 reference

25 December 2017

0 references

Jorge E Toblli

1

1 reference

25 December 2017

Marina C Muñoz

2

1 reference

25 December 2017

Gabriel Cao

3

1 reference

25 December 2017

José Mella

4

1 reference

25 December 2017

Lisandro Pereyra

5

1 reference

25 December 2017

Ricardo Mastai

6

1 reference

25 December 2017

language of work or name

1 reference

24 January 2007

1 reference

25 December 2017

published in

Obesity

1 reference

25 December 2017

volume

16

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

770-776

1 reference

25 December 2017

https://api.crossref.org/works/10.1038%2FOBY.2007.114

1 reference

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Steatohepatitis: a tale of two "hits"?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Liver fibrogenesis: a new role for the renin-angiotensin system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Angiotensin-converting enzyme inhibition reduces lipid deposits in myocardium and improves left ventricular function of obese zucker rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Insulin resistance: a metabolic pathway to chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Risk reduction therapy for syndrome X: comparison of several treatments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Interleukin-6 depletion selectively improves hepatic insulin action in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Animal models of steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

The role of leptin in progression of non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Leptin receptor-deficient Zucker (fa/fa) rat retards the development of pig serum-induced liver fibrosis with Kupffer cell dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

31 March 2020

Identifiers

DOI

10.1038/OBY.2007.114

1 reference

25 December 2017

1 reference

25 December 2017